Insider Trading Tracker: Live US Stock Disclosures & Insider Buying made on Sep 12, 2024

Advanced/Help

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Showing you 400 results sorted by most recent dates. Subscribe to see a larger data set

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Bicara Therapeutics Inc	Kiran Mazumdar-Shaw	Director, Ten Percent Owner		12 Sep 2024	40,000,000	0	-		-	Series Seed Redeemable Convertible Preferred Stock
Bicara Therapeutics Inc	Kiran Mazumdar-Shaw	Director, Ten Percent Owner		12 Sep 2024	9,990,144	0	-		-	Series Seed Redeemable Convertible Preferred Stock
Zenas Biopharma Inc	Patrick G. Enright	Director		12 Sep 2024	8,714,293	0	-		-	Series C Convertible Preferred Stock
Zenas Biopharma Inc	Patrick G. Enright	Director		12 Sep 2024	6,284,933	0	-		-	Series B Convertible Preferred Stock
Holley Inc (Class A)	David S. Lobel	Director, Ten Percent Owner	Other type of transaction at price $ 0.00 per share.	12 Sep 2024	5,873,567	43,300,317	-		0	Common Stock
Bicara Therapeutics Inc	Kiran Mazumdar-Shaw	Director, Ten Percent Owner		12 Sep 2024	4,327,365	4,443,122	-		0	Common Stock
Bicara Therapeutics Inc	Kiran Mazumdar-Shaw	Director, Ten Percent Owner		12 Sep 2024	4,000,000	0	-		-	Series Seed Redeemable Convertible Preferred Stock
Zenas Biopharma Inc	Oliver	Director, Chief Executive Officer		12 Sep 2024	3,230,268	0	-		-	Series B Convertible Preferred Stock
Bicara Therapeutics Inc	Kiran Mazumdar-Shaw	Director, Ten Percent Owner		12 Sep 2024	3,000,000	0	-		-	Series Seed Redeemable Convertible Preferred Stock
Zenas Biopharma Inc	Patrick G. Enright	Director		12 Sep 2024	2,904,764	0	-		-	Series C Convertible Preferred Stock
Pegasystems Inc	Alan Trefler	Director, C.E.O. & Chairman, Ten Percent Owner	Gift of securities by or to the insider at price $ 0.00 per share.	12 Sep 2024	1,605,503	1,605,503 (2%)	2%		0	Common stock
Pegasystems Inc	Alan Trefler	Director, C.E.O. & Chairman, Ten Percent Owner	Gift of securities by or to the insider at price $ 0.00 per share.	12 Sep 2024	1,605,503	0 (0%)	2%		0	Common stock
Transocean Ltd	Frederik W. Mohn	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 4.13 per share.	12 Sep 2024	1,500,000	91,074,894 (14%)	0%	4.1	6,195,000	Registered Shares
Zenas Biopharma Inc	Oliver	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	1,486,000	1,486,000	-		-	Stock Option (Right to Buy)
Zenas Biopharma Inc	Oliver	Director, Chief Executive Officer		12 Sep 2024	1,428,571	0	-		-	Series Seed Convertible Preferred Stock
Bicara Therapeutics Inc	Kiran Mazumdar-Shaw	Director, Ten Percent Owner		12 Sep 2024	1,080,775	1,080,775	-		0	Common Stock
Zenas Biopharma Inc	Patrick G. Enright	Director		12 Sep 2024	1,003,592	1,727,404	-		-	Common Stock
Zenas Biopharma Inc	Oliver	Director, Chief Executive Officer		12 Sep 2024	941,088	0	-		-	Series A Convertible Preferred Stock
Celsius Holdings Inc	John Fieldly	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	900,000	0	-		-	Common Stock Option
Celsius Holdings Inc	John Fieldly	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.61 per share.	12 Sep 2024	900,000	1,887,337 (2%)	1%	1.6	1,449,000	Common Stock, $0.001 par value per share
Zenas Biopharma Inc	Patrick G. Enright	Director		12 Sep 2024	723,812	723,812	-		-	Common Stock
Intuitive Machines Inc (Class A)	Kamal Seyed Ghaffarian	Director, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	570,705	42,930,186	-		-	Common Units
Intuitive Machines Inc (Class A)	Kamal Seyed Ghaffarian	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 6.08 per share.	12 Sep 2024	570,705	3,551,606	-	6.1	3,469,487	Class A Common Stock
Intuitive Machines Inc (Class A)	Kamal Seyed Ghaffarian	Director, Ten Percent Owner	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Sep 2024	570,705	38,305,657	-		-	Class C Common Stock
Intuitive Machines Inc (Class A)	Kamal Seyed Ghaffarian	Director, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	570,705	4,122,311	-		-	Class A Common Stock
Celsius Holdings Inc	John Fieldly	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 34.36 per share.	12 Sep 2024	551,421	1,261,069 (1%)	0%	34.4	18,946,826	Common Stock, $0.001 par value per share
LoanDepot Inc (Class A)	Anthony Hsieh	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 2.27 per share.	12 Sep 2024	537,488	1,875,868 (3%)	0%	2.3	1,219,668	Class A Common Stock
Cleanspark Inc	Zachary K. Bradford	Director, CEO and President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	450,000	3,245,863 (66%)	9%		0	Common Stock
Cleanspark Inc	Zachary K. Bradford	Director, CEO and President	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	450,000	450,000	-		-	Restricted Stock Unit
Intuitive Machines Inc (Class A)	Stephen Altemus	Director, Chief Executive Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	440,288	1,351,207	-		-	Class A Common Stock
Intuitive Machines Inc (Class A)	Stephen Altemus	Director, Chief Executive Officer, Ten Percent Owner	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Sep 2024	440,288	14,638,159	-		-	Class C Common Stock
Intuitive Machines Inc (Class A)	Stephen Altemus	Director, Chief Executive Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 6.03 per share.	12 Sep 2024	440,288	910,919	-	6.0	2,654,364	Class A Common Stock
Intuitive Machines Inc (Class A)	Stephen Altemus	Director, Chief Executive Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	440,288	16,398,669	-		-	Common Units
Zenas Biopharma Inc	Patrick G. Enright	Director	Purchase of securities on an exchange or from another person at price $ 17.00 per share.	12 Sep 2024	440,000	774,530	-	17	7,480,000	Common Stock
Bicara Therapeutics Inc	Kiran Mazumdar-Shaw	Director, Ten Percent Owner		12 Sep 2024	432,736	432,736	-		0	Common Stock
Zenas Biopharma Inc	Oliver	Director, Chief Executive Officer		12 Sep 2024	418,996	0	-		-	Series B Convertible Preferred Stock
Pfizer	Albert Bourla	Director, Chairman & CEO	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Sep 2024	413,280	0	-		-	Stock Appreciation Rights
Pfizer	Albert Bourla	Director, Chairman & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	413,280	413,280	-		-	Stock Appreciation Rights
Pfizer	Albert Bourla	Director, Chairman & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	412,081	412,081	-		-	Stock Appreciation Rights
Pfizer	Albert Bourla	Director, Chairman & CEO	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Sep 2024	412,081	0	-		-	Stock Appreciation Rights
Zenas Biopharma Inc	Orlando Oliveira	Chief Commercial Officer		12 Sep 2024	410,000	410,000	-		-	Stock Option (Right to Buy)
Cleanspark Inc	S. Matthew Schultz	Director, Executive Chairman	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	405,000	405,000	-		-	Restricted Stock Unit
Cleanspark Inc	S. Matthew Schultz	Director, Executive Chairman	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	405,000	2,703,975 (55%)	8%		0	Common Stock
Celsius Holdings Inc	John Fieldly	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	397,827	0	-		-	Common Stock Option
Celsius Holdings Inc	John Fieldly	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.93 per share.	12 Sep 2024	397,827	987,337 (1%)	0%	1.9	767,806	Common Stock, $0.001 par value per share
Zenas Biopharma Inc	Oliver	Director, Chief Executive Officer		12 Sep 2024	372,017	1,652,039	-		-	Common Stock
Liquidia Corp	Paul B. Manning	Director	Purchase of securities on an exchange or from another person at price $ 8.90 per share.	12 Sep 2024	337,078	816,311 (2%)	1%	8.9	2,999,994	Common Stock
Zenas Biopharma Inc	Patrick G. Enright	Director		12 Sep 2024	334,530	334,530	-		-	Common Stock
Bicara Therapeutics Inc	Kiran Mazumdar-Shaw	Director, Ten Percent Owner		12 Sep 2024	324,552	324,552	-		0	Common Stock
Nexentis Technologies Inc	David Palach	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	320,000	420,000	-		0	Restricted Shares of Common Stock
Intuitive Machines Inc (Class A)	Stephen Altemus	Director, Chief Executive Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	306,456	1,217,375	-		-	Class A Common Stock
Intuitive Machines Inc (Class A)	Stephen Altemus	Director, Chief Executive Officer, Ten Percent Owner	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Sep 2024	306,456	14,331,703	-		-	Class C Common Stock
Intuitive Machines Inc (Class A)	Stephen Altemus	Director, Chief Executive Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 6.00 per share.	12 Sep 2024	306,456	910,919	-	6.0	1,839,686	Class A Common Stock
Intuitive Machines Inc (Class A)	Stephen Altemus	Director, Chief Executive Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	306,456	16,092,213	-		-	Common Units
V2X Inc	Dino M. Cusumano	Director		12 Sep 2024	300,000	16,200,001 (140%)	2%	45.5	13,644,000	Common Stock
Clarivate PLC	Andrew M. Snyder	Director	Gift of securities by or to the insider at price $ 0.00 per share.	12 Sep 2024	238,500	238,500	-		0	Ordinary Shares
HP Inc.	Enrique J. Lores	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	211,501	423,002	-		-	Performance Contingent Stock Options
HP Inc.	Enrique J. Lores	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 33.16 per share.	12 Sep 2024	211,501	3 (0%)	0%	33.2	7,013,373	Common Stock
HP Inc.	Enrique J. Lores	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 28.48 per share.	12 Sep 2024	211,501	211,504 (0%)	0%	28.5	6,023,548	Common Stock
Zenas Biopharma Inc	Joseph Farmer	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	206,000	206,000	-		-	Stock Option (Right to Buy)
Fathom Holdings Inc	Joshua Harley	Ten Percent Owner	Gift of securities by or to the insider at price $ 0.00 per share.	12 Sep 2024	200,000	2,029,383	-		0	Common Stock
Intuitive Machines Inc (Class A)	Timothy Crain	SVP and Chief Growth Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 6.05 per share.	12 Sep 2024	197,637	362,810	-	6.1	1,195,941	Class A Common Stock
Intuitive Machines Inc (Class A)	Timothy Crain	SVP and Chief Growth Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	197,637	10,616,416	-		-	Common Units
Intuitive Machines Inc (Class A)	Timothy Crain	SVP and Chief Growth Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	197,637	560,447	-		-	Class A Common Stock
Intuitive Machines Inc (Class A)	Timothy Crain	SVP and Chief Growth Officer, Ten Percent Owner	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Sep 2024	197,637	9,501,457	-		-	Class C Common Stock
Applovin Corp (Class A)	Victoria Valenzuela	CLO & Corp. Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.45 per share.	12 Sep 2024	187,500	540,116	-	7.5	1,397,494	Class A Common Stock
Applovin Corp (Class A)	Victoria Valenzuela	CLO & Corp. Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	187,500	0	-		-	Stock Option (Right to Buy)
Devon Energy	Clay M. Gaspar	EVP and COO	Gift of securities by or to the insider at price $ 0.00 per share.	12 Sep 2024	186,289	0 (0%)	0%		0	Common Stock
Devon Energy	Clay M. Gaspar	EVP and COO	Gift of securities by or to the insider at price $ 0.00 per share.	12 Sep 2024	186,289	186,289 (0%)	0%		0	Common Stock
Celsius Holdings Inc	John Fieldly	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	180,396	0	-		-	Common Stock Option
Celsius Holdings Inc	John Fieldly	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.16 per share.	12 Sep 2024	180,396	589,510 (0%)	0%	1.2	209,259	Common Stock, $0.001 par value per share
Cleanspark Inc	S. Matthew Schultz	Director, Executive Chairman	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.25 per share.	12 Sep 2024	178,201	2,525,774 (51%)	3%	9.2	1,648,359	Common Stock
Cleanspark Inc	S. Matthew Schultz	Director, Executive Chairman	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.25 per share.	12 Sep 2024	178,201	2,120,774 (43%)	3%	9.2	1,648,359	Common Stock
Cleanspark Inc	Zachary K. Bradford	Director, CEO and President	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.25 per share.	12 Sep 2024	177,075	3,068,788 (63%)	3%	9.3	1,637,944	Common Stock
Cleanspark Inc	Zachary K. Bradford	Director, CEO and President		12 Sep 2024	177,075	2,618,788 (53%)	3%	9.3	1,637,944	Common Stock
Zenas Biopharma Inc	Oliver	Director, Chief Executive Officer		12 Sep 2024	164,523	1,280,022	-		-	Common Stock
Nexentis Technologies Inc	Lital Barda	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	160,000	202,857	-		0	Restricted Shares of Common Stock
Zenas Biopharma Inc	Jennifer A. Fox	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	155,000	155,000	-		-	Stock Option (Right to Buy)
Live Nation Entertainment	Michael Rapino	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.33 per share.	12 Sep 2024	150,000	3,800,964 (1%)	0%	25.3	3,799,500	Common Stock
Live Nation Entertainment	Michael Rapino	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	150,000	0	-		-	Stock Option (buy)
Colgate-Palmolive	Noel R. Wallace	Director, Chairman, President & CEO		12 Sep 2024	145,696	145,696	-		-	Stock Option (Right to Buy)
Viatris	Rajiv Malik	Director		12 Sep 2024	139,681	505,838 (0%)	0%	11.7	1,628,164	Common Stock
Pfizer	Mikael Dolsten	President R&D		12 Sep 2024	137,760	0	-		-	Stock Appreciation Rights
Pfizer	Mikael Dolsten	President R&D		12 Sep 2024	137,760	137,760	-		-	Stock Appreciation Rights
Neumora Therapeutics Inc	Daljit Singh Aurora	Chief Strategy Officer	Gift of securities by or to the insider at price $ 0.00 per share.	12 Sep 2024	137,538	137,538	-		-	Stock Option (Right to Buy)
Neumora Therapeutics Inc	Daljit Singh Aurora	Chief Strategy Officer	Gift of securities by or to the insider at price $ 0.00 per share.	12 Sep 2024	137,538	40,890	-		-	Stock Option (Right to Buy)
Neumora Therapeutics Inc	Daljit Singh Aurora	Chief Strategy Officer	Gift of securities by or to the insider at price $ 0.00 per share.	12 Sep 2024	136,210	136,210	-		-	Stock Option (Right to Buy)
Neumora Therapeutics Inc	Daljit Singh Aurora	Chief Strategy Officer	Gift of securities by or to the insider at price $ 0.00 per share.	12 Sep 2024	136,210	207,901	-		-	Stock Option (Right to Buy)
Eos Energy Enterprises Inc (Class A)	Jeffrey S. Bornstein	Director	Sale of securities on an exchange or to another person at price $ 2.63 per share.	12 Sep 2024	132,720	7,999	-	2.6	349,054	Common Stock
Universal Health Services (Class B)	Alan B. Miller	Director, Executive Chairman, Ten Percent Owner	Payment of exercise price or tax liability using portion of securities received from the company at price $ 231.36 per share.	12 Sep 2024	129,371	1,205,602 (1%)	0%	231.4	29,931,275	Class B Common Stock
Traeger Inc	Dominic Blosil	Chief Financial Officer		12 Sep 2024	128,150	1,353,304	-		0	Common Stock
Abbott	Robert B. Ford	Director, CHAIRMAN AND CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 47.00 per share.	12 Sep 2024	127,436	347,495 (0%)	0%	47	5,989,492	Common shares without par value
Abbott	Robert B. Ford	Director, CHAIRMAN AND CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	127,436	0	-		-	Option (right to buy)
Pfizer	Mikael Dolsten	President R&D		12 Sep 2024	126,794	126,794	-		-	Stock Appreciation Rights
Pfizer	Mikael Dolsten	President R&D		12 Sep 2024	126,794	0	-		-	Stock Appreciation Rights
MBX Biosciences Inc	Peter Kent Hawryluk	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	120,436	120,436	-		-	Stock Option (Right to Buy)
Universal Health Services (Class B)	Alan B. Miller	Director, Executive Chairman, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	116,466	232,933	-		-	Option To Purchase Class B Common Stock
Universal Health Services (Class B)	Alan B. Miller	Director, Executive Chairman, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.46 per share.	12 Sep 2024	116,466	1,236,640 (1%)	0%	74.5	8,672,058	Class B Common Stock
STAG Industrial Inc	Benjamin S. Butcher	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	116,024	745,482	-		-	LTIP Units
Applovin Corp (Class A)	Victoria Valenzuela	CLO & Corp. Secretary	Sale of securities on an exchange or to another person at price $ 105.31 per share.	12 Sep 2024	112,542	427,574	-	105.3	11,851,798	Class A Common Stock
Zenas Biopharma Inc	Oliver	Director, Chief Executive Officer		12 Sep 2024	108,381	112,901	-		-	Common Stock
QuantumScape Corp (Class A)	Michael O. McCarthy	CHIEF LEGAL OFFICER	Sale of securities on an exchange or to another person at price $ 5.90 per share.	12 Sep 2024	106,084	1,181,884	-	5.9	625,630	Class A Common Stock
QuantumScape Corp (Class A)	Michael O. McCarthy	CHIEF LEGAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.38 per share.	12 Sep 2024	106,084	1,287,968	-	2.4	252,162	Class A Common Stock
QuantumScape Corp (Class A)	Michael O. McCarthy	CHIEF LEGAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	106,084	400,000	-		-	Stock Option (right to buy)
Mission Produce Inc Insider Trade	Jay A. Pack	Director	Sale of securities on an exchange or to another person at price $ 13.14 per share.	12 Sep 2024	104,111	619,439	-	13.1	1,368,019	COMMON STOCK
Pfizer	David M. Denton	Chief Financial Officer & EVP	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	103,320	103,320	-		-	Stock Appreciation Rights
Pfizer	David M. Denton	Chief Financial Officer & EVP	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Sep 2024	103,320	0	-		-	Stock Appreciation Rights
Pfizer	Aamir Malik	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	103,320	103,320	-		-	Stock Appreciation Rights
Pfizer	Aamir Malik	Executive Vice President	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Sep 2024	103,320	0	-		-	Stock Appreciation Rights
Caredx Inc	Keith Kennedy	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	100,651	100,651	-		-	Employee Stock Option (right to buy)
QuantumScape Corp (Class A)	Michael O. McCarthy	CHIEF LEGAL OFFICER	Sale of securities on an exchange or to another person at price $ 5.80 per share.	12 Sep 2024	100,038	1,181,884	-	5.8	579,890	Class A Common Stock
Fathom Holdings Inc	Scott N. Flanders	Director	Purchase of securities on an exchange or from another person at price $ 2.85 per share.	12 Sep 2024	100,000	824,688	-	2.9	285,000	Common Stock
Fathom Holdings Inc	Joshua Harley	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 2.85 per share.	12 Sep 2024	100,000	2,229,383	-	2.9	285,000	Common Stock
Levi Strauss & Co. - Ordinary Shares Cls A Results Board Meeting	David A. Friedman	Director		12 Sep 2024	100,000	254,178 (0%)	0%		0	Class A Common Stock
Levi Strauss & Co. - Ordinary Shares Cls A Results Board Meeting	David A. Friedman	Director		12 Sep 2024	100,000	1,156,540	-		-	Class B Common Stock
Neuronetics Inc	Robert A. Cascella	Director	Purchase of securities on an exchange or from another person at price $ 0.75 per share.	12 Sep 2024	100,000	453,098 (2%)	0%	0.8	75,000	Common Stock
Live Nation Entertainment	Michael Rapino	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 97.50 per share.	12 Sep 2024	98,849	3,702,115 (1%)	0%	97.5	9,637,778	Common Stock
Universal Health Services (Class B)	Alan B. Miller	Director, Executive Chairman, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	98,333	196,667	-		-	Option To Purchase Class B Common Stock
Universal Health Services (Class B)	Alan B. Miller	Director, Executive Chairman, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 67.69 per share.	12 Sep 2024	98,333	1,334,973 (1%)	0%	67.7	6,656,161	Class B Common Stock
QuantumScape Corp (Class A)	Michael O. McCarthy	CHIEF LEGAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.38 per share.	12 Sep 2024	97,177	1,281,922	-	2.4	230,990	Class A Common Stock
QuantumScape Corp (Class A)	Michael O. McCarthy	CHIEF LEGAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	97,177	506,084	-		-	Stock Option (right to buy)
TKO (Class A)	Ariel Z. Emanuel	Director, Chief Executive Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	97,040	291,122	-		-	Restricted Stock Unit
TKO (Class A)	Ariel Z. Emanuel	Director, Chief Executive Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	97,040	109,571	-		0	Class A Common Stock
Fractyl Health Inc	Jay D. Caplan	President, Chief Product Off.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.70 per share.	12 Sep 2024	95,484	95,484	-	1.7	162,323	Common Stock
Fractyl Health Inc	Jay D. Caplan	President, Chief Product Off.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	95,484	0	-		-	Stock Option
Marvell Tech Inc Dividend	Fouad G. Tamer	Director	Sale of securities on an exchange or to another person at price $ 74.16 per share.	12 Sep 2024	92,000	351,193 (0%)	0%	74.2	6,822,720	Common Stock
Pfizer	Aamir Malik	Executive Vice President	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Sep 2024	84,529	0	-		-	Stock Appreciation Rights
Pfizer	Aamir Malik	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	84,529	84,529	-		-	Stock Appreciation Rights
Mereo Biopharma Grp PLC (ADR)	Alexandra Hughes-Wilson	See Remarks	Sale of securities on an exchange or to another person at price $ 4.22 per share.	12 Sep 2024	84,008	50,475	-	4.2	354,598	American Depositary Shares representing Ordinary Shares
Rivian Automotive Inc (Class A) Stock Sale	Robert J. Scaringe	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 13.68 per share.	12 Sep 2024	83,333	886,526	-	13.7	1,140,012	Class A Common Stock
Rivian Automotive Inc (Class A) Stock Sale	Robert J. Scaringe	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	83,333	8,130,501	-		-	Stock Option
Rivian Automotive Inc (Class A) Stock Sale	Robert J. Scaringe	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.63 per share.	12 Sep 2024	83,333	969,859	-	2.6	219,016	Class A Common Stock
Pfizer	David M. Denton	Chief Financial Officer & EVP	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Sep 2024	80,703	0	-		-	Stock Appreciation Rights
Pfizer	David M. Denton	Chief Financial Officer & EVP	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	80,703	80,703	-		-	Stock Appreciation Rights
Pfizer	Douglas M. Lankler	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	80,360	80,360	-		-	Stock Appreciation Rights
Pfizer	Douglas M. Lankler	Executive Vice President	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Sep 2024	80,360	0	-		-	Stock Appreciation Rights
Abbott	Robert B. Ford	Director, CHAIRMAN AND CEO	Sale of securities on an exchange or to another person at price $ 116.04 per share.	12 Sep 2024	80,299	281,439 (0%)	0%	116.0	9,317,896	Common shares without par value
Caredx Inc	Jessica Meng	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	75,488	75,488	-		-	Employee Stock Option (right to buy)
Gap Inc	Horacio Barbeito	President & CEO, Old Navy	Sale of securities on an exchange or to another person at price $ 20.00 per share.	12 Sep 2024	75,385	0 (0%)	0%	20	1,507,700	Common Stock
Celsius Holdings Inc	John Fieldly	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 32.80 per share.	12 Sep 2024	74,847	1,812,490 (2%)	0%	32.8	2,454,982	Common Stock, $0.001 par value per share
Seaport Entertainment Grp Inc	D.	Director, Chief Executive Officer		12 Sep 2024	74,359	200,814	-		0	Common Stock
Toast Inc (Class A) Analyst Upgrade	Stephen Fredette	Director, President	Sale of securities on an exchange or to another person at price $ 25.57 per share.	12 Sep 2024	70,475	2,426,784	-	25.6	1,801,764	Class A Common Stock
Caredx Inc	Keith Kennedy	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	70,101	70,101 (0%)	0%		0	Common Stock
Covista Inc	Lisa Warner Wardell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	67,976	1,565	-		-	Employee Stock Option (Right to Buy)
Covista Inc	Lisa Warner Wardell	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 32.03 per share.	12 Sep 2024	67,976	173,061 (0%)	0%	32.0	2,177,271	Common Stock
Covista Inc	Lisa Warner Wardell	Director	Sale of securities on an exchange or to another person at price $ 72.86 per share.	12 Sep 2024	67,976	105,085 (0%)	0%	72.9	4,952,684	Common Stock
Fractyl Health Inc	Jay D. Caplan	President, Chief Product Off.	Sale of securities on an exchange or to another person at price $ 2.90 per share.	12 Sep 2024	65,000	30,484	-	2.9	188,474	Common Stock
NVIDIA Investment	Jen-Hsun Huang	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 118.78 per share.	12 Sep 2024	64,318	75,470,979 (12%)	0%	118.8	7,639,428	Common Stock
Pfizer	Douglas M. Lankler	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	63,397	63,397	-		-	Stock Appreciation Rights
Pfizer	Douglas M. Lankler	Executive Vice President	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Sep 2024	63,397	0	-		-	Stock Appreciation Rights
Abbott	Robert B. Ford	Director, CHAIRMAN AND CEO	Sale of securities on an exchange or to another person at price $ 116.90 per share.	12 Sep 2024	61,380	220,059 (0%)	0%	116.9	7,175,322	Common shares without par value
TKO (Class A)	Mark S. Shapiro	Director, See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	60,651	73,182	-		0	Class A Common Stock
TKO (Class A)	Mark S. Shapiro	Director, See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	60,651	0	-		-	Restricted Stock Unit
Viatris	Rajiv Malik	Director		12 Sep 2024	60,319	0 (0%)	0%	11.7	706,553	Common Stock
QuantumScape Corp (Class A)	Kevin Hettrich	CHIEF FINANCIAL OFFICER	Sale of securities on an exchange or to another person at price $ 5.78 per share.	12 Sep 2024	58,000	1,073,022	-	5.8	335,217	Class A Common Stock
Intuitive Machines Inc (Class A)	Kamal Seyed Ghaffarian	Director, Ten Percent Owner	Other type of transaction at price $ 5.63 per share.	12 Sep 2024	56,838	3,494,768	-	5.6	319,998	Class A Common Stock
NVIDIA Investment	Jen-Hsun Huang	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 119.26 per share.	12 Sep 2024	55,143	75,415,836 (12%)	0%	119.3	6,576,442	Common Stock
Zurn Elkay Water Soln Corp	Sudhanshu Chhabra	VP-Zurn Business Systems		12 Sep 2024	52,851	133,002 (0%)	0%	12.7	669,622	Common Stock
Zurn Elkay Water Soln Corp	Sudhanshu Chhabra	VP-Zurn Business Systems		12 Sep 2024	52,851	0	-		-	Stock Option (right to buy)
Zurn Elkay Water Soln Corp	Sudhanshu Chhabra	VP-Zurn Business Systems		12 Sep 2024	52,851	80,151 (0%)	0%	32.5	1,720,157	Common Stock
Caredx Inc	Jessica Meng	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	52,576	52,576 (0%)	0%		0	Common Stock
Public Storage Analyst Downgrade	Nathaniel A. Vitan	Chief Legal Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	51,637	12,909	-		-	AO LTIP Units
Mission Produce Inc Insider Trade	Luis A. Gonzalez	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 13.28 per share.	12 Sep 2024	51,615	7,219,614	-	13.3	685,447	COMMON STOCK
NVIDIA Investment	Jen-Hsun Huang	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 119.43 per share.	12 Sep 2024	51,208	75,554,273 (12%)	0%	119.4	6,115,782	Common Stock
Nerdy Inc (Class A)	Abigail Blunt	Director	Purchase of securities on an exchange or from another person at price $ 0.91 per share.	12 Sep 2024	51,000	101,045	-	0.9	46,410	Class A Common Stock
Intrusion Inc	Anthony J. Levecchio	Director	Grant, award, or other acquisition of securities at price $ 1.38 per share.	12 Sep 2024	50,724	71,335	-	1.4	69,999	Common Stock
Intrusion Inc	James F. Gero	Director	Grant, award, or other acquisition of securities at price $ 1.38 per share.	12 Sep 2024	50,724	94,053	-	1.4	69,999	Common Stock
KVH Ind Inc	Stephen H. Deckoff	Director, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 4.47 per share.	12 Sep 2024	50,200	3,357,398 (18%)	0%	4.5	224,158	Common Stock
Artiva Biotherapeutics Inc	Jennifer Kinsbruner Bush	COO, CLO, Secy, Compliance Off	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	50,000	72,799	-		0	Common Stock
Artiva Biotherapeutics Inc	Neha Krishnamohan	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	50,000	50,000	-		0	Common Stock
STAG Industrial Inc	Benjamin S. Butcher	Director		12 Sep 2024	50,000	58,758 (0%)	0%		-	Common Stock
STAG Industrial Inc	Benjamin S. Butcher	Director		12 Sep 2024	50,000	9,320	-		-	Partnership Units
STAG Industrial Inc	Benjamin S. Butcher	Director		12 Sep 2024	50,000	59,320	-		-	Partnership Units
STAG Industrial Inc	Benjamin S. Butcher	Director		12 Sep 2024	50,000	695,482	-		-	LTIP Units
STAG Industrial Inc	Benjamin S. Butcher	Director	Sale of securities on an exchange or to another person at price $ 39.23 per share.	12 Sep 2024	50,000	8,758 (0%)	0%	39.2	1,961,695	Common Stock
Fastenal Results Board Meeting	Daniel L. Florness	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.50 per share.	12 Sep 2024	50,000	336,018 (0%)	0%	23.5	1,175,000	Common Stock
Fastenal Results Board Meeting	Daniel L. Florness	Director, CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	50,000	0	-		-	Employee Stock Option (Right to Buy)
Fastenal Results Board Meeting	Daniel L. Florness	Director, CEO	Sale of securities on an exchange or to another person at price $ 69.68 per share.	12 Sep 2024	50,000	286,018 (0%)	0%	69.7	3,484,050	Common Stock
Toast Inc (Class A) Analyst Upgrade	Stephen Fredette	Director, President	Gift of securities by or to the insider at price $ 0.00 per share.	12 Sep 2024	50,000	2,345,685	-		0	Class A Common Stock
Twin Vee PowerCats Co	Michael P. Dickerson	Chief Financial Officer		12 Sep 2024	50,000	50,000	-	0.5	24,500	Common Stock
DoorDash	Andy Fang	Director	Other type of transaction at price $ 0.00 per share.	12 Sep 2024	50,000	7,098,604	-		-	Class B Common Stock
DoorDash	Andy Fang	Director	Other type of transaction at price $ 0.00 per share.	12 Sep 2024	50,000	50,000	-		0	Class A Common Stock
DoorDash	Andy Fang	Director	Other type of transaction at price $ 0.00 per share.	12 Sep 2024	50,000	7,148,604	-		-	Class B Common Stock
DoorDash	Andy Fang	Director	Sale of securities on an exchange or to another person at price $ 131.94 per share.	12 Sep 2024	50,000	0	-	131.9	6,597,200	Class A Common Stock
DoorDash	Andy Fang	Director	Other type of transaction at price $ 0.00 per share.	12 Sep 2024	50,000	50,000	-		0	Class A Common Stock
LoanDepot Inc (Class A)	Anthony Hsieh	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 2.26 per share.	12 Sep 2024	50,000	2,413,356 (3%)	0%	2.3	113,140	Class A Common Stock
TKO (Class A)	Ariel Z. Emanuel	Director, Chief Executive Officer, Ten Percent Owner	Payment of exercise price or tax liability using portion of securities received from the company at price $ 114.99 per share.	12 Sep 2024	49,197	60,374	-	115.0	5,657,163	Class A Common Stock
Zenas Biopharma Inc	Oliver	Director, Chief Executive Officer		12 Sep 2024	48,254	161,155	-		-	Common Stock
Public Storage Analyst Downgrade	Nathaniel A. Vitan	Chief Legal Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	46,473	30,983	-		-	AO LTIP Units
Pfizer	Payal Sahni	Executive Vice President	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Sep 2024	45,920	0	-		-	Stock Appreciation Rights
Pfizer	Payal Sahni	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	45,920	45,920	-		-	Stock Appreciation Rights
Pfizer	Michael McDermott	Executive Vice President	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Sep 2024	45,920	0	-		-	Stock Appreciation Rights
Pfizer	Michael McDermott	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	45,920	45,920	-		-	Stock Appreciation Rights
MBX Biosciences Inc	Salomon Azoulay	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	45,011	45,011	-		-	Stock Option (Right to Buy)
Applovin Corp (Class A)	Adam Foroughi	Director, CEO & Chairperson, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 105.46 per share.	12 Sep 2024	44,835	3,992,050	-	105.5	4,728,299	Class A Common Stock
Live Nation Entertainment	Joe Berchtold	President & CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.33 per share.	12 Sep 2024	44,403	596,032 (0%)	0%	25.3	1,124,728	Common Stock
Live Nation Entertainment	Joe Berchtold	President & CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	44,403	0	-		-	Stock Option (buy)
Innovate Corp	Paul K. Voigt	Interim CEO	Purchase of securities on an exchange or from another person at price $ 3.80 per share.	12 Sep 2024	43,785	211,655 (0%)	0%	3.8	166,383	Common Stock
Pfizer	Lidia L. Fonseca	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	43,624	43,624	-		-	Stock Appreciation Rights
Pfizer	Lidia L. Fonseca	Executive Vice President	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Sep 2024	43,624	0	-		-	Stock Appreciation Rights
Pfizer	Sally Susman	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	43,624	43,624	-		-	Stock Appreciation Rights
Pfizer	Sally Susman	Executive Vice President	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Sep 2024	43,624	0	-		-	Stock Appreciation Rights
Applovin Corp (Class A)	Adam Foroughi	Director, CEO & Chairperson, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 111.55 per share.	12 Sep 2024	42,788	3,919,608	-	111.5	4,773,001	Class A Common Stock
MBX Biosciences Inc	Richard B. Bartram	Chief Financial Officer		12 Sep 2024	42,578	42,578	-		-	Stock Option (Right to Buy)
Pfizer	Payal Sahni	Executive Vice President	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Sep 2024	42,265	0	-		-	Stock Appreciation Rights
Pfizer	Payal Sahni	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	42,265	42,265	-		-	Stock Appreciation Rights
Sprott Inc	Arthur Richards Rule	Ten Percent Owner	Sale or transfer of securities back to the company at price $ 41.45 per share.	12 Sep 2024	41,610	2,638,457	-	41.5	1,724,735	COM NEW
CompoSecure Inc (Class A)	Adam Lowe	Chief Product & Innov. Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.31 per share.	12 Sep 2024	40,658	1,332,877	-	4.3	175,236	Class A Common Stock
CompoSecure Inc (Class A)	Adam Lowe	Chief Product & Innov. Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	40,658	167,133	-		-	Stock Option (Right to Buy)
CompoSecure Inc (Class A)	Adam Lowe	Chief Product & Innov. Officer	Sale of securities on an exchange or to another person at price $ 12.06 per share.	12 Sep 2024	40,658	1,292,219	-	12.1	490,335	Class A Common Stock
Pfizer	Sally Susman	Executive Vice President	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Sep 2024	40,151	0	-		-	Stock Appreciation Rights
Pfizer	Sally Susman	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	40,151	40,151	-		-	Stock Appreciation Rights
Mereo Biopharma Grp PLC (ADR)	Alexandra Hughes-Wilson	See Remarks	Sale of securities on an exchange or to another person at price $ 4.47 per share.	12 Sep 2024	40,029	150,787	-	4.5	179,038	American Depositary Shares representing Ordinary Shares
Cleanspark Inc	Andrew Zimmerman	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	40,000	594,391 (12%)	0%		0	Common Stock
Cleanspark Inc	Andrew Zimmerman	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	40,000	40,000	-		-	Restricted Stock Unit
Amylyx Pharma Inc	James M. Frates	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 2.53 per share.	12 Sep 2024	40,000	233,464	-	2.5	101,368	Common Stock
QuinStreet Inc	Gregory Wong	CFO	Sale of securities on an exchange or to another person at price $ 18.66 per share.	12 Sep 2024	40,000	385,207 (0%)	0%	18.7	746,400	Common Stock
22nd Century Grp Inc	Lawrence D. Firestone	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.27 per share.	12 Sep 2024	39,000	54,250 (0%)	0%	0.3	10,468	Common Stock
DoorDash	Andy Fang	Director	Sale of securities on an exchange or to another person at price $ 130.12 per share.	12 Sep 2024	38,898	11,102	-	130.1	5,061,330	Class A Common Stock
Colgate-Palmolive	Stanley J. Sutula	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	38,411	38,411	-		-	Stock Option (Right to Buy)
Pfizer	Lidia L. Fonseca	Executive Vice President	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Sep 2024	38,038	0	-		-	Stock Appreciation Rights
Pfizer	Lidia L. Fonseca	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	38,038	38,038	-		-	Stock Appreciation Rights
Seaport Entertainment Grp Inc	Matthew M. Partridge	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	37,323	71,466	-		0	Common Stock
Zenas Biopharma Inc	Ting Xiao	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	37,000	37,000	-		-	Stock Option (Right to Buy)
Zenas Biopharma Inc	Patrick G. Enright	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	37,000	37,000	-		-	Stock Option (Right to Buy)
Zenas Biopharma Inc	Hongbo Lu	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	37,000	37,000	-		-	Stock Option (Right to Buy)
Zenas Biopharma Inc	James P. Boylan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	37,000	37,000	-		-	Stock Option (Right to Buy)
Apollo Global (Class A) (New) Takeover Bid	James R Belardi	Director, CEO of Athene Holding Ltd.	Gift of securities by or to the insider at price $ 0.00 per share.	12 Sep 2024	36,202	558,380 (0%)	0%		0	Common Stock
Mission Produce Inc Insider Trade	Stephen J. Barnard	Director, CEO	Sale of securities on an exchange or to another person at price $ 13.02 per share.	12 Sep 2024	36,200	0	-	13.0	471,324	COMMON STOCK
Dream Finders Homes Inc (Class A)	W. Radford Lovett	Director, Ten Percent Owner		12 Sep 2024	35,930	4,796,498	-	34.5	1,239,944	Class A common stock, par value $0.01 per share
Intuitive Machines Inc (Class A)	Kamal Seyed Ghaffarian	Director, Ten Percent Owner	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Sep 2024	35,751	38,269,906	-		-	Class C Common Stock
Intuitive Machines Inc (Class A)	Kamal Seyed Ghaffarian	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 6.00 per share.	12 Sep 2024	35,751	3,494,768	-	6.0	214,585	Class A Common Stock
Intuitive Machines Inc (Class A)	Kamal Seyed Ghaffarian	Director, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	35,751	42,894,435	-		-	Common Units
Intuitive Machines Inc (Class A)	Kamal Seyed Ghaffarian	Director, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	35,751	3,530,519	-		-	Class A Common Stock
Twin Vee PowerCats Co	Karl J. Zimmer	President	Purchase of securities on an exchange or from another person at price $ 0.45 per share.	12 Sep 2024	35,138	85,138	-	0.4	15,773	Common Stock
Viasat Inc	Richard A. Baldridge	Director	Purchase of securities on an exchange or from another person at price $ 15.00 per share.	12 Sep 2024	35,000	55,000 (0%)	0%	15	525,000	$.0001 par value common stock
QuantumScape Corp (Class A)	Kevin Hettrich	CHIEF FINANCIAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.38 per share.	12 Sep 2024	34,607	1,131,022	-	2.4	82,261	Class A Common Stock
QuantumScape Corp (Class A)	Kevin Hettrich	CHIEF FINANCIAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	34,607	367,567	-		-	Stock Option (right to buy)
Amylyx Pharma Inc	Joshua Cohen	Director, Co-Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	34,449	1,857	-		-	Stock Option (right to buy)
Amylyx Pharma Inc	Joshua Cohen	Director, Co-Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.57 per share.	12 Sep 2024	34,449	3,237,301	-	1.6	54,085	Common Stock
Applovin Corp (Class A)	Adam Foroughi	Director, CEO & Chairperson, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 112.33 per share.	12 Sep 2024	34,391	3,885,217	-	112.3	3,863,141	Class A Common Stock
Ares Management Corp (Class A)	Bennett Rosenthal	Director, Co-Founder & Chairman of PEG	Sale of securities on an exchange or to another person at price $ 143.65 per share.	12 Sep 2024	34,331	0 (0%)	0%	143.6	4,931,648	Class A Common Stock
Pfizer	Michael McDermott	Executive Vice President	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Sep 2024	34,234	0	-		-	Stock Appreciation Rights
Pfizer	Michael McDermott	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	34,234	34,234	-		-	Stock Appreciation Rights
Treace Medical Concepts Inc	Sean F. Scanlan	Chief Innovation Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	33,750	0	-		-	Stock Option (Right to Buy)
Treace Medical Concepts Inc	Sean F. Scanlan	Chief Innovation Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.10 per share.	12 Sep 2024	33,750	250,074	-	0.1	3,281	Common Stock
DENTSPLY Sirona Inc	Simon D. Campion	Director, President, CEO & Member of BOD		12 Sep 2024	33,729	260,044 (0%)	0%	25.4	856,379	Common Stock
IES Holdings Inc	Jeffrey L. Gendell	Director, Chief Executive Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 158.77 per share.	12 Sep 2024	33,152	11,003,832 (51%)	0%	158.8	5,263,543	Common Stock, par value $0.01 per share
Neumora Therapeutics Inc	Robert Lenz	Head of R&D		12 Sep 2024	32,948	369,993	-	11.4	376,665	Common Stock
Harmonic Inc	Neven Haltmayer	SVP & GM, Video Business	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	32,690	32,690	-		-	Restricted Stock Units
Krispy Kreme Inc	Jeremiah Ashukian	EVP & Chief Financial Officer		12 Sep 2024	32,553	218,979	-		0	Common Stock
IES Holdings Inc	Jeffrey L. Gendell	Director, Chief Executive Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 160.00 per share.	12 Sep 2024	32,378	10,939,814 (51%)	0%	160	5,180,480	Common Stock, par value $0.01 per share
Colgate-Palmolive	Prabha Parameswaran	Grp Pres, Growth & Strategy		12 Sep 2024	31,954	31,954	-		-	Stock Option (Right to Buy)
Grindr Inc (Class A)	Zachary Katz	GC and Head of Global Affairs	Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.78 per share.	12 Sep 2024	31,422	278,578	-	11.8	370,151	Common Stock
LoanDepot Inc (Class A)	Joseph J Grassi	Chief Risk Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	31,250	53,093 (0%)	0%		-	Class A Common Stock
LoanDepot Inc (Class A)	Joseph J Grassi	Chief Risk Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	31,250	62,500	-		-	Restricted Stock Units
IES Holdings Inc	Jeffrey L. Gendell	Director, Chief Executive Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 157.82 per share.	12 Sep 2024	31,106	11,053,739 (52%)	0%	157.8	4,909,149	Common Stock, par value $0.01 per share
Toast Inc (Class A) Analyst Upgrade	Stephen Fredette	Director, President	Sale of securities on an exchange or to another person at price $ 26.09 per share.	12 Sep 2024	31,099	2,395,685	-	26.1	811,497	Class A Common Stock
TKO (Class A)	Mark S. Shapiro	Director, See Remarks	Sale of securities on an exchange or to another person at price $ 114.76 per share.	12 Sep 2024	31,026	42,156	-	114.8	3,560,544	Class A Common Stock
Blue Bird Corp	Philip Horlock	Chief Executive Officer		12 Sep 2024	30,044	299,812 (1%)	0%	49.2	1,478,165	Common Stock, par value $0.0001 per share
Eos Energy Enterprises Inc (Class A)	Jeffrey S. Bornstein	Director	Sale of securities on an exchange or to another person at price $ 2.62 per share.	12 Sep 2024	30,000	84,929	-	2.6	78,600	Common Stock
Neumora Therapeutics Inc	Daljit Singh Aurora	Chief Strategy Officer	Gift of securities by or to the insider at price $ 0.00 per share.	12 Sep 2024	29,737	29,737	-		-	Stock Option (Right to Buy)
Neumora Therapeutics Inc	Daljit Singh Aurora	Chief Strategy Officer	Gift of securities by or to the insider at price $ 0.00 per share.	12 Sep 2024	29,737	72,221	-		-	Stock Option (Right to Buy)
Blue Bird Corp	Philip Horlock	Chief Executive Officer		12 Sep 2024	29,708	299,812 (1%)	0%	50.8	1,509,166	Common Stock, par value $0.0001 per share
Blue Bird Corp	Philip Horlock	Chief Executive Officer		12 Sep 2024	29,708	329,520 (1%)	0%	18.1	537,715	Common Stock, par value $0.0001 per share
Live Nation Entertainment	Joe Berchtold	President & CFO	Sale of securities on an exchange or to another person at price $ 97.49 per share.	12 Sep 2024	28,812	567,220 (0%)	0%	97.5	2,808,882	Common Stock
NVIDIA Investment	Jen-Hsun Huang	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 118.59 per share.	12 Sep 2024	28,767	75,605,481 (12%)	0%	118.6	3,411,596	Common Stock
Dream Finders Homes Inc (Class A)	W. Radford Lovett	Director, Ten Percent Owner		12 Sep 2024	27,022	4,769,376	-	34.5	931,448	Class A common stock, par value $0.01 per share
Insmed Inc	Martina Flammer	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 74.90 per share.	12 Sep 2024	26,969	106,134 (0%)	0%	74.9	2,019,978	Common Stock
Insmed Inc	Martina Flammer	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.03 per share.	12 Sep 2024	26,969	133,103 (0%)	0%	34.0	917,755	Common Stock
Insmed Inc	Martina Flammer	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	26,969	27,116	-		-	Stock Option (right to buy)
Ares Management Corp (Class A)	Bennett Rosenthal	Director, Co-Founder & Chairman of PEG	Sale of securities on an exchange or to another person at price $ 143.01 per share.	12 Sep 2024	26,768	34,331 (0%)	0%	143.0	3,828,092	Class A Common Stock
Dream Finders Homes Inc (Class A)	W. Radford Lovett	Director, Ten Percent Owner		12 Sep 2024	26,755	4,836,398	-	32.6	872,481	Class A common stock, par value $0.01 per share
Standex Intl Corp	David A. Dunbar	Director, President/CEO/Chairman	Gift of securities by or to the insider at price $ 0.00 per share.	12 Sep 2024	26,381	5,398 (0%)	0%		0	Common Stock
Standex Intl Corp	David A. Dunbar	Director, President/CEO/Chairman	Gift of securities by or to the insider at price $ 0.00 per share.	12 Sep 2024	26,381	80,614 (0%)	0%		0	Common Stock
Colgate-Palmolive	Jennifer M. Daniels	CLO and Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	25,563	25,563	-		-	Stock Option (Right to Buy)
Colgate-Palmolive	Panagiotis Tsourapas	Grp Pres, Eur& Developing Mkts	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	25,563	25,563	-		-	Stock Option (Right to Buy)
Artiva Biotherapeutics Inc	Christopher Horan	Chief Tech Operations Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	25,000	25,000	-		0	Common Stock
Alignment Healthcare Inc	Joseph Konowiecki	Director	Sale of securities on an exchange or to another person at price $ 11.00 per share.	12 Sep 2024	25,000	1,183,221	-	11.0	275,093	Common Stock
Alignment Healthcare Inc	Joseph Konowiecki	Director	Sale of securities on an exchange or to another person at price $ 12.00 per share.	12 Sep 2024	25,000	1,158,221	-	12.0	300,013	Common Stock
Alignment Healthcare Inc	Hakan Kardes	Chief Experience Officer	Sale of securities on an exchange or to another person at price $ 11.48 per share.	12 Sep 2024	25,000	380,444	-	11.5	287,053	Common Stock
Gilead Sciences	Merdad V. Parsey	Chief Medical Officer		12 Sep 2024	25,000	146,670	-		-	Non-qualified Stock Option (Right to Buy)
Gilead Sciences	Merdad V. Parsey	Chief Medical Officer		12 Sep 2024	25,000	123,435 (0%)	0%	57.9	1,448,000	Common Stock
Primoris Services Corp	John P. Schauerman	Director		12 Sep 2024	25,000	162,281 (0%)	0%	54.0	1,351,213	Common Stock
Roku Inc (Class A)	Anthony Wood	Director, CEO and Chairman BOD, Ten Percent Owner		12 Sep 2024	25,000	25,000 (0%)	0%		-	Class A Common Stock
Roku Inc (Class A)	Anthony Wood	Director, CEO and Chairman BOD, Ten Percent Owner		12 Sep 2024	25,000	17,103,111	-		-	Class B Common Stock
Roku Inc (Class A)	Anthony Wood	Director, CEO and Chairman BOD, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 75.00 per share.	12 Sep 2024	25,000	0 (0%)	0%	75	1,875,000	Class A Common Stock
Pfizer	Rady A. Johnson	Executive Vice President		12 Sep 2024	24,797	0	-		-	Stock Appreciation Rights
Pfizer	Rady A. Johnson	Executive Vice President		12 Sep 2024	24,797	24,797	-		-	Stock Appreciation Rights
Bicara Therapeutics Inc	Kiran Mazumdar-Shaw	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	23,746	23,746	-		-	Stock Option (Right to Buy)
Bicara Therapeutics Inc	Jake Simson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	23,746	23,746	-		-	Stock Option (Right to Buy)
Bicara Therapeutics Inc	Scott Robertson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	23,746	23,746	-		-	Stock Option (Right to Buy)
Pfizer	Rady A. Johnson	Executive Vice President		12 Sep 2024	22,823	0	-		-	Stock Appreciation Rights
Pfizer	Rady A. Johnson	Executive Vice President		12 Sep 2024	22,823	22,823	-		-	Stock Appreciation Rights
Cleanspark Inc	Thomas Leigh Wood	Director	Sale of securities on an exchange or to another person at price $ 9.24 per share.	12 Sep 2024	22,222	137,050 (2%)	0%	9.2	205,331	Common Stock
ADP	Carlos A. Rodriguez	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	21,950	43,900	-		-	Stock Option (Right to Buy)
ADP	Carlos A. Rodriguez	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 206.86 per share.	12 Sep 2024	21,950	58,691 (0%)	0%	206.9	4,540,577	Common Stock
ADP	Carlos A. Rodriguez	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 206.86 per share.	12 Sep 2024	21,949	58,690 (0%)	0%	206.9	4,540,370	Common Stock
ADP	Carlos A. Rodriguez	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	21,949	65,850	-		-	Stock Option (Right to Buy)
Gilead Sciences	Merdad V. Parsey	Chief Medical Officer		12 Sep 2024	21,246	102,189 (0%)	0%	84.5	1,795,287	Common Stock
Mereo Biopharma Grp PLC (ADR)	Charles Sermon	General Counsel	Sale of securities on an exchange or to another person at price $ 4.22 per share.	12 Sep 2024	20,946	219,061	-	4.2	88,413	American Depositary Shares representing Ordinary Shares
Colgate-Palmolive	Noel R. Wallace	Director, Chairman, President & CEO		12 Sep 2024	20,689	307,848 (0%)	0%		0	Common Stock
Fluent Inc	Donald Patrick	Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 2.67 per share.	12 Sep 2024	20,250	329,063 (0%)	0%	2.7	54,068	Common Stock
ThredUp Inc (Class A)	Noam Paransky	Director	Purchase of securities on an exchange or from another person at price $ 0.82 per share.	12 Sep 2024	20,008	586,452	-	0.8	16,407	Class A Common Stock
Artiva Biotherapeutics Inc	Thorsten Graef	Chief Medical Officer		12 Sep 2024	20,000	20,000	-		0	Common Stock
Viasat Inc	Richard A. Baldridge	Director	Purchase of securities on an exchange or from another person at price $ 14.75 per share.	12 Sep 2024	20,000	20,000 (0%)	0%	14.8	295,000	$.0001 par value common stock
Blend Labs Inc (Class A)	Winnie Ling	HEAD OF LEGAL AND PEOPLE	Sale of securities on an exchange or to another person at price $ 3.33 per share.	12 Sep 2024	20,000	286,416	-	3.3	66,676	Class A Common Stock
Fuel Tech Inc	Vincent J. Arnone	Director, President & CEO	Purchase of securities on an exchange or from another person at price $ 1.02 per share.	12 Sep 2024	20,000	460,513 (1%)	0%	1.0	20,400	Common Stock
Intapp Inc	Michele Murgel	Chief People & Places Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	20,000	89,283	-		-	Employee Stock Option (Right to Buy)
Intapp Inc	Michele Murgel	Chief People & Places Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.00 per share.	12 Sep 2024	20,000	195,874	-	12	240,000	Common Stock
Intapp Inc	Michele Murgel	Chief People & Places Officer	Sale of securities on an exchange or to another person at price $ 44.18 per share.	12 Sep 2024	20,000	175,874	-	44.2	883,522	Common Stock
Scynexis Inc	David Angulo	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 1.37 per share.	12 Sep 2024	20,000	507,871 (0%)	0%	1.4	27,400	Common Stock
ThredUp Inc (Class A)	Noam Paransky	Director	Purchase of securities on an exchange or from another person at price $ 0.80 per share.	12 Sep 2024	20,000	566,444	-	0.8	16,000	Class A Common Stock
Agilon Health Inc	Steven J. Sell	Director, CEO & President		12 Sep 2024	20,000	67,590	-	3.4	67,188	Common Stock
Pulmonx Corp	Glendon E. French	Director	Sale of securities on an exchange or to another person at price $ 8.09 per share.	12 Sep 2024	20,000	1,111,974	-	8.1	161,800	Common Stock
Unity Software Inc	Felix The	SVP Product & Technology, Grow		12 Sep 2024	19,850	433,829	-	17.2	341,619	Common Stock
Blue Bird Corp	Philip Horlock	Chief Executive Officer		12 Sep 2024	19,833	0	-		-	Stock Option (right to buy)
Public Storage Analyst Downgrade	Nathaniel A. Vitan	Chief Legal Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	19,762	31,011	-		-	LTIP Units
Mereo Biopharma Grp PLC (ADR)	Chrisitne Ann Fox	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 4.22 per share.	12 Sep 2024	19,158	89,285	-	4.2	80,866	American Depositary Shares representing Ordinary Shares
Zenas Biopharma Inc	Patricia L. Allen	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	18,500	18,500	-		-	Stock Option (Right to Buy)
Zenas Biopharma Inc	John J. Orloff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	18,500	18,500	-		-	Stock Option (Right to Buy)
NVIDIA Investment	Jen-Hsun Huang	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 120.29 per share.	12 Sep 2024	18,437	75,535,836 (12%)	0%	120.3	2,217,796	Common Stock
Blue Bird Corp	Philip Horlock	Chief Executive Officer		12 Sep 2024	18,239	0	-		-	Stock Option (right to buy)
Blue Bird Corp	Philip Horlock	Chief Executive Officer		12 Sep 2024	18,239	318,051 (1%)	0%	16.2	295,472	Common Stock, par value $0.0001 per share
SKYX Platforms Corp	Leonard J. Sokolow	Director, Co-Chief Executive Officer	Gift of securities by or to the insider at price $ 0.00 per share.	12 Sep 2024	18,000	741,220 (1%)	0%		0	Common Stock, no par value
Public Storage Analyst Downgrade	Nathaniel A. Vitan	Chief Legal Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	17,659	48,670	-		-	LTIP Units
Village Farms Intl Inc	Michael A. DeGiglio	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 0.99 per share.	12 Sep 2024	17,579	9,673,239 (18%)	0%	1.0	17,438	Common Shares
ADP	Carlos A. Rodriguez	Director	Sale of securities on an exchange or to another person at price $ 277.70 per share.	12 Sep 2024	17,267	36,741 (0%)	0%	277.7	4,795,103	Common Stock
CuriosityStream Inc - Ordinary Shares- Class A	Jonathan S. Huberman	Director	Sale of securities on an exchange or to another person at price $ 1.67 per share.	12 Sep 2024	16,848	0	-	1.7	28,212	Common Stock
Criteo S.A (ADR)	Ryan Damon	Chief Legal Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	16,845	0	-		-	Stock Option (right to buy)
Criteo S.A (ADR)	Ryan Damon	Chief Legal Officer	Sale of securities on an exchange or to another person at price $ 44.37 per share.	12 Sep 2024	16,845	121,219 (0%)	0%	44.4	747,413	Ordinary Shares
Criteo S.A (ADR)	Ryan Damon	Chief Legal Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.66 per share.	12 Sep 2024	16,845	138,064 (0%)	0%	20.7	348,018	Ordinary Shares
Mission Produce Inc Insider Trade	Stephen J. Barnard	Director, CEO	Sale of securities on an exchange or to another person at price $ 13.02 per share.	12 Sep 2024	16,720	181,389	-	13.0	217,694	COMMON STOCK
Colgate-Palmolive	Sally Massey	Chief Human Resources Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	16,689	16,689	-		-	Stock Option (Right to Buy)
Mereo Biopharma Grp PLC (ADR)	Alexandra Hughes-Wilson	See Remarks	Sale of securities on an exchange or to another person at price $ 4.22 per share.	12 Sep 2024	16,304	134,483	-	4.2	68,819	American Depositary Shares representing Ordinary Shares
MBX Biosciences Inc	James M. Cornelius	Director		12 Sep 2024	15,963	15,963	-		-	Stock Option (Right to Buy)
MBX Biosciences Inc	Patrick J. Heron	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	15,963	15,963	-		-	Stock Option (Right to Buy)
MBX Biosciences Inc	Ora H. Pescovitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	15,963	15,963	-		-	Stock Option (Right to Buy)
MBX Biosciences Inc	Tiba Aynechi	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	15,963	15,963	-		-	Stock Option (Right to Buy)
MBX Biosciences Inc	Carl L. Gordon	Director, Ten Percent Owner		12 Sep 2024	15,963	15,963	-		-	Stock Option (Right to Buy)
MBX Biosciences Inc	Edward T. Mathers	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	15,963	15,963	-		-	Stock Option (Right to Buy)
MBX Biosciences Inc	Steven Ryder	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	15,963	15,963	-		-	Stock Option (Right to Buy)
Gilead Sciences	Johanna Mercier	Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 84.23 per share.	12 Sep 2024	15,925	91,559 (0%)	0%	84.2	1,341,363	Common Stock
Cleanspark Inc	Andrew Zimmerman	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.25 per share.	12 Sep 2024	15,740	578,651 (11%)	0%	9.3	145,595	Common Stock
Cleanspark Inc	Andrew Zimmerman	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.25 per share.	12 Sep 2024	15,740	578,651 (11%)	0%	9.3	145,595	Common Stock
Roku Inc (Class A)	Charles Collier	President, Roku Media	Sale of securities on an exchange or to another person at price $ 75.00 per share.	12 Sep 2024	15,454	200 (0%)	0%	75	1,159,050	Class A Common Stock
INmune Bio Inc	Raymond J. Tesi	Director, President and CEO, Ten Percent Owner		12 Sep 2024	15,380	15,380	-		-	Common Stock Warrants (right to buy)
INmune Bio Inc	Raymond J. Tesi	Director, President and CEO, Ten Percent Owner		12 Sep 2024	15,380	1,554,106 (14%)	0%	6.4	98,048	Common Stock
Coinbase Global Inc (Class A)	Brian Armstrong	Director, Chairman and CEO, Ten Percent Owner		12 Sep 2024	15,375	15,901	-		0	Class A Common Stock
Coinbase Global Inc (Class A)	Brian Armstrong	Director, Chairman and CEO, Ten Percent Owner		12 Sep 2024	15,375	25,656,225	-		-	Class B Common Stock
Affirm Holdings Inc (Class A)	Christa S. Quarles	Director	Sale of securities on an exchange or to another person at price $ 40.02 per share.	12 Sep 2024	14,400	141,903	-	40.0	576,288	Class A Common Stock
Dave & Buster`s Entertainment Inc	Steve Klohn	SVP Chief Information Officer	Sale of securities on an exchange or to another person at price $ 31.10 per share.	12 Sep 2024	14,287	14,657 (0%)	0%	31.1	444,297	Common Stock
Weave Comm Inc	Alan Taylor	Chief Financial Officer		12 Sep 2024	14,270	529,115	-	10.6	151,119	Common Stock
Abbott	Robert B. Ford	Director, CHAIRMAN AND CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	14,243	0	-		-	Option (right to buy)
Abbott	Robert B. Ford	Director, CHAIRMAN AND CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 48.90 per share.	12 Sep 2024	14,243	361,738 (0%)	0%	48.9	696,483	Common shares without par value
Gartner	Eugene A. Hall	Director, Chairman and CEO	Sale of securities on an exchange or to another person at price $ 505.75 per share.	12 Sep 2024	14,030	1,151,197 (1%)	0%	505.8	7,095,673	Common Stock
Insmed Inc	Martina Flammer	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	13,436	13,680	-		-	Stock Option (right to buy)
Insmed Inc	Martina Flammer	Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.03 per share.	12 Sep 2024	13,436	119,570 (0%)	0%	34.0	457,227	Common Stock
Insmed Inc	Martina Flammer	Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 74.92 per share.	12 Sep 2024	13,436	106,134 (0%)	0%	74.9	1,006,625	Common Stock
Gilead Sciences	Johanna Mercier	Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 83.25 per share.	12 Sep 2024	13,432	78,127 (0%)	0%	83.3	1,118,214	Common Stock
Gen Digital	Eric K. Brandt	Director	Gift of securities by or to the insider at price $ 0.00 per share.	12 Sep 2024	13,340	10,038 (0%)	0%		0	Common Stock
Gen Digital	Eric K. Brandt	Director	Gift of securities by or to the insider at price $ 0.00 per share.	12 Sep 2024	13,340	59,646 (0%)	0%		0	Common Stock
Gen Digital	Susan P. Barsamian	Director	Gift of securities by or to the insider at price $ 0.00 per share.	12 Sep 2024	13,340	81,025 (0%)	0%		0	Common Stock
Gen Digital	Susan P. Barsamian	Director	Gift of securities by or to the insider at price $ 0.00 per share.	12 Sep 2024	13,340	10,038 (0%)	0%		0	Common Stock
Applovin Corp (Class A)	Adam Foroughi	Director, CEO & Chairperson, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 102.38 per share.	12 Sep 2024	12,678	4,060,039	-	102.4	1,297,974	Class A Common Stock
Applovin Corp (Class A)	Victoria Valenzuela	CLO & Corp. Secretary	Sale of securities on an exchange or to another person at price $ 111.92 per share.	12 Sep 2024	12,500	415,074	-	111.9	1,399,000	Class A Common Stock
VICI Properties	Gabriel F. Wasserman	Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 33.61 per share.	12 Sep 2024	12,500	33,187 (0%)	0%	33.6	420,125	Common Stock
NVIDIA Investment	Jen-Hsun Huang	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 117.50 per share.	12 Sep 2024	12,474	75,634,248 (12%)	0%	117.5	1,465,707	Common Stock
IES Holdings Inc	Jeffrey L. Gendell	Director, Chief Executive Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 158.69 per share.	12 Sep 2024	12,372	11,041,367 (52%)	0%	158.7	1,963,313	Common Stock, par value $0.01 per share
Ares Management Corp (Class A)	Ryan Berry	Chief Mktg. & Strategy Officer		12 Sep 2024	12,200	414,502 (0%)	0%	148.4	1,810,480	Class A Common Stock
Pfizer	Jennifer B. Damico	SVP & Controller	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Sep 2024	12,169	0	-		-	Stock Appreciation Rights
Pfizer	Jennifer B. Damico	SVP & Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	12,169	12,169	-		-	Stock Appreciation Rights
Applovin Corp (Class A)	Adam Foroughi	Director, CEO & Chairperson, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 103.44 per share.	12 Sep 2024	11,925	4,048,114	-	103.4	1,233,522	Class A Common Stock
Celsius Holdings Inc	John Fieldly	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.21 per share.	12 Sep 2024	11,922	409,114 (0%)	0%	14.2	169,412	Common Stock, $0.001 par value per share
Celsius Holdings Inc	John Fieldly	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	11,922	0	-		-	Common Stock Option
Applovin Corp (Class A)	Adam Foroughi	Director, CEO & Chairperson, Ten Percent Owner	Gift of securities by or to the insider at price $ 0.00 per share.	12 Sep 2024	11,765	4,085,217	-		0	Class A Common Stock
Pfizer	Jennifer B. Damico	SVP & Controller	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Sep 2024	11,623	0	-		-	Stock Appreciation Rights
Pfizer	Jennifer B. Damico	SVP & Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	11,623	11,623	-		-	Stock Appreciation Rights
Applovin Corp (Class A)	Adam Foroughi	Director, CEO & Chairperson, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 104.46 per share.	12 Sep 2024	11,229	4,036,885	-	104.5	1,172,981	Class A Common Stock
IES Holdings Inc	Jeffrey L. Gendell	Director, Chief Executive Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 161.19 per share.	12 Sep 2024	11,166	10,983,679 (51%)	0%	161.2	1,799,848	Common Stock, par value $0.01 per share
DoorDash	Andy Fang	Director	Sale of securities on an exchange or to another person at price $ 130.50 per share.	12 Sep 2024	11,102	0	-	130.5	1,448,778	Class A Common Stock
Nasdaq	John Zecca	Executive Vice President	Sale of securities on an exchange or to another person at price $ 71.97 per share.	12 Sep 2024	11,000	113,263 (0%)	0%	72.0	791,670	Common Stock, par value $0.01 per share
Colgate-Palmolive	John W. Kooyman	Chief of Staff	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	10,815	10,815	-		-	Stock Option (Right to Buy)
Applovin Corp (Class A)	Adam Foroughi	Director, CEO & Chairperson, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 109.45 per share.	12 Sep 2024	10,612	3,972,343	-	109.4	1,161,483	Class A Common Stock
Pfizer	Douglas M. Lankler	Executive Vice President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	10,566	10,566	-		-	Stock Appreciation Rights
Pfizer	Douglas M. Lankler	Executive Vice President	Sale or transfer of securities back to the company at price $ 0.00 per share.	12 Sep 2024	10,566	0	-		-	Stock Appreciation Rights
CuriosityStream Inc - Ordinary Shares- Class A	Mike Nikzad	Director	Sale of securities on an exchange or to another person at price $ 1.64 per share.	12 Sep 2024	10,547	100,000	-	1.6	17,297	Common Stock
Grocery Outlet Holding Corp	Robert Joseph Sheedy	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	10,389	0	-		-	Stock Options (Right to Buy)
Grocery Outlet Holding Corp	Robert Joseph Sheedy	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.81 per share.	12 Sep 2024	10,389	96,472 (0%)	0%	3.8	39,582	Common Stock
Chegg Inc	Nathan Schultz	Director, CEO and President		12 Sep 2024	10,225	688,180 (0%)	0%	1.8	18,916	Common Stock
Unity Software Inc	Felix The	SVP Product & Technology, Grow		12 Sep 2024	10,150	423,679	-	19.2	195,185	Common Stock
Artiva Biotherapeutics Inc	Heather Raymon	SVP, Research and Development	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Sep 2024	10,000	10,000	-		0	Common Stock
IZEA Worldwide Inc	Lindsay A. Gardner	Director	Purchase of securities on an exchange or from another person at price $ 2.69 per share.	12 Sep 2024	10,000	95,118 (0%)	0%	2.7	26,929	Common Stock
Liquidity Services Inc	Jorge A. Celaya	EVP & Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 22.03 per share.	12 Sep 2024	10,000	52,407 (0%)	0%	22.0	220,300	Common Stock
Ares Management Corp (Class A)	Ryan Berry	Chief Mktg. & Strategy Officer		12 Sep 2024	10,000	426,702 (0%)	0%	146.2	1,462,300	Class A Common Stock
IES Holdings Inc	Jeffrey L. Gendell	Director, Chief Executive Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 162.00 per share.	12 Sep 2024	10,000	10,973,679 (51%)	0%	162	1,620,000	Common Stock, par value $0.01 per share
US Foods Holding Corp	Dirk J. Locascio	EVP, Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Sep 2024	10,000	55,252	-		-	Employee Stock Option (right to buy)
US Foods Holding Corp	Dirk J. Locascio	EVP, Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 57.95 per share.	12 Sep 2024	10,000	88,563 (0%)	0%	58.0	579,500	Common Stock
US Foods Holding Corp	Dirk J. Locascio	EVP, Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.29 per share.	12 Sep 2024	10,000	98,563 (0%)	0%	13.3	132,900	Common Stock
Sprott Inc	Arthur Richards Rule	Ten Percent Owner	Sale or transfer of securities back to the company at price $ 41.30 per share.	12 Sep 2024	10,000	2,604,537	-	41.3	413,000	COM NEW

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.

Insider trading for US stocks based on disclosures made made on Sep 12, 2024

Monitor US insider transactions and discover insider buying and selling of stocks on Sep 12, 2024.

Screeners based on Insider Trading parameters